← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eclipse Bioinnovations Inc
San Diego, CA
$5,376,315
Total funding
4
Grants
Funding over time
peak $1.3M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,376,315 · 4
By mechanism
R44$5,026,565 · 3
R43$349,750 · 1
Investigators at Eclipse Bioinnovations Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A robust kit, standards, and software for identifying RNA binding protein targets$1,278,018
R44 · FY2017 · HG
eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening$1,148,465
R44 · FY2025 · GM
Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide$1,137,682
R44 · FY2021 · HG
Development of chimeric read amplification into a robust method for profiling targets of specific microRNAs and global amplification of all microRNA:mRNA pairings transcriptome-wide$861,551
R44 · FY2022 · HG
Unambiguous transcriptome-wide identification of microRNA:mRNA interactions through enhanced chimeric read amplification$349,750
R43 · FY2019 · HG
A robust kit, standards, and software for identifying RNA binding protein targets$305,093
R44 · FY2018 · HG
eMOA: A Multi-Omic Service for Mechanism of Action Determination in Drug Screening$295,756
R44 · FY2024 · GM